Dyne Therapeutics
200 hedge funds and large institutions have $4.03B invested in Dyne Therapeutics in 2024 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 75 increasing their positions, 54 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3% more capital invested
Capital invested by funds: $3.92B → $4.03B (+$117M)
1.42% less ownership
Funds ownership: 113.4% → 111.98% (-1.4%)
29% less funds holding in top 10
Funds holding in top 10: 14 → 10 (-4)
Holders
200
Holding in Top 10
10
Calls
$10.7M
Puts
$8.75M
Top Buyers
| 1 | +$133M | |
| 2 | +$78.6M | |
| 3 | +$77.1M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$31.4M |
| 5 |
Man Group
London,
United Kingdom
|
+$25.8M |
Top Sellers
| 1 | -$67.9M | |
| 2 | -$53.5M | |
| 3 | -$51.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$49.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$33.2M |